We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Danaher Purchases Life Science Businesses for US $1.1 Billion

By LabMedica International staff writers
Posted on 07 Sep 2009
Danaher Corp. More...
(DHR; Washington, DC, USA) will acquire life science instrumentation businesses from MDS Inc. (Mississauga, ON, Canada) and Life Technologies (Carlsbad, CA, USA). The company has signed a definitive agreement with MDS Inc. to acquire its analytical technologies division, which includes a 50% ownership position in Applied Biosystems (Foster City, CA, USA)/MDS Sciex joint venture (AB Sciex), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation (Sunnyvale, CA, USA), a bioresearch and analytical instrumentation company.

In a separate but related transaction, Danaher signed a definitive agreement with Life Technologies Corp. to acquire the remaining 50% ownership position in AB Sciex. After completion of both transactions, Danaher will own outright AB Sciex and MDS. The aggregate purchase price for the combined transactions is $1.1 billion, including debt assumed and net of cash acquired.

The transaction with MDS Inc. is subject to approval of the MDS shareholders. Both transactions are subject to regulatory approval and customary closing conditions, including the absence of material adverse change with respect to the acquired businesses. Danaher expects the transactions to close in the fourth quarter of 2009.

The acquired businesses will operate within Danaher's medical technologies segment and will expand the segment's annual revenues by more than $650 million. Danaher's life sciences and diagnostics annual revenues will increase to more than $2 billion.

AB Sciex designs and manufactures mass spectrometers, and instruments used by clinicians and researchers to identify and quantify specific molecules in complex samples. Typical applications include diagnostics testing, drug development, food and environmental safety testing, and proteomics research. MDS supplies bioanalytical instrumentation.

Danaher designs, manufactures, and markets products and services to professional, medical, industrial, and commercial customers. Its portfolio of brands is well recognized in each of its markets.

Related Links:
Danaher Corp.
MDS Inc.
AB Sciex
Life Technologies Corp.
Molecular Devices Corporation



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Candida Glabrata Test
ELIchrom Glabrata
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.